Enzymic and non‐enzymic cross‐linking mechanisms in relation to turnover of collagen: relevance to aging and exercise

The molecular mechanisms involved in the aging of collagen and consequent increase in mechanical strength and stiffness occur in a series of enzymic and non‐enzymic intermolecular cross‐links. The enzymic mechanism involves divalent aldimine intermolecular cross‐links derived from the reaction of aldehydes which then mature to trivalent cross‐links and further stabilize the collagen fiber and is now well known. Recent studies have demonstrated that the rate of turnover and level of telopeptide lysyl hydroxylation modifies the nature of the cross‐link and hence the mechanical strength of the fiber.

[1]  A J Bailey,et al.  Biochemical changes in the collagenous matrix of osteoporotic avian bone. , 1995, The Biochemical journal.

[2]  A. Cerami,et al.  High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Slatter,et al.  Identification of a New Cross-link and Unique Histidine Adduct from Bovine Serum Albumin Incubated with Malondialdehyde* , 2004, Journal of Biological Chemistry.

[4]  R. G. Paul,et al.  Reactions of Lipid-derived Malondialdehyde with Collagen* , 1999, The Journal of Biological Chemistry.

[5]  R. G. Paul,et al.  Mechanisms of maturation and ageing of collagen , 1998, Mechanisms of Ageing and Development.

[6]  D. Eyre,et al.  Molecular Site Specificity of Pyridinoline and Pyrrole Cross-links in Type I Collagen of Human Bone* , 1996, The Journal of Biological Chemistry.

[7]  S. Rahbar,et al.  Novel inhibitors of advanced glycation endproducts. , 2003, Biochemical and biophysical research communications.

[8]  T. Henle,et al.  N-Terminal pyrazinones: a new class of peptide-bound advanced glycation end-products , 2004, Amino Acids.

[9]  P. Gallop,et al.  Structure of hemoglobin AIc: Nature of the N-terminal β chain blocking group , 1968 .

[10]  J. Baynes,et al.  Characterization of an Imidazolium Salt Formed from Glyoxal and N.alpha.-Hippuryllysine: A Model for Maillard Reaction Crosslinks in Proteins , 1995 .

[11]  L. Lanyon,et al.  Mechanical Strain and Bone Cell Function: A Review , 2002, Osteoporosis International.

[12]  R. Schmidt,et al.  Effect of Aminoguanidine on the Frequency of Neuroaxonal Dystrophy in the Superior Mesenteric Sympathetic Autonomic Ganglia of Rats With Streptozocin-Induced Diabetes , 1996, Diabetes.

[13]  T J Sims,et al.  Mechanical Properties of Adult Vertebral Cancellous Bone: Correlation With Collagen Intermolecular Cross‐Links , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  A. Bailey,et al.  Age-Related Changes in the Biochemical Properties of Human Cancellous Bone Collagen: Relationship to Bone Strength , 1999, Calcified Tissue International.

[15]  A. Goodship,et al.  Treadmill exercise-induced tendon hypertrophy: assessment of tendons with different mechanical functions. , 2010, Equine veterinary journal. Supplement.

[16]  A. Bailey,et al.  The chemistry of the collagen cross-links. The characterization of fraction C, a possible artifact produced during the reduction of collagen fibres with borohydride. , 1973, The Biochemical journal.

[17]  V. Monnier,et al.  Accelerated age-related browning of human collagen in diabetes mellitus. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Robins,et al.  Isoaspartyl bond formation within N-terminal sequences of collagen type I: implications for their use as markers of collagen degradation. , 1999, Clinical science.

[19]  A. Jenkins,et al.  Pyridoxamine, an Inhibitor of Advanced Glycation Reactions, Also Inhibits Advanced Lipoxidation Reactions , 2000, The Journal of Biological Chemistry.

[20]  V. Monnier,et al.  Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. , 1989, The Journal of biological chemistry.

[21]  D. Mercer,et al.  Identification, expression, and tissue distribution of the three rat lysyl hydroxylase isoforms. , 2003, Biochemical and biophysical research communications.

[22]  D Fujimoto,et al.  The structure of pyridinoline, a collagen crosslink. , 1978, Biochemical and biophysical research communications.

[23]  J. Bernhagen,et al.  An agent cleaving glucose-derived protein crosslinks in vitro and in vivo , 1996, Nature.

[24]  Allen J. Bailey,et al.  Molecular mechanisms of ageing in connective tissues , 2001, Mechanisms of Ageing and Development.

[25]  S. Clarke Propensity for spontaneous succinimide formation from aspartyl and asparaginyl residues in cellular proteins. , 2009, International journal of peptide and protein research.

[26]  A. Bailey,et al.  Collagen biochemistry of avian bone: comparison of bone type and skeletal site. , 1999, British poultry science.

[27]  M. Yamauchi,et al.  Structure and formation of a stable histidine-based trifunctional cross-link in skin collagen. , 1987, The Journal of biological chemistry.

[28]  J. O'brien The Maillard reaction in aging, diabetes, and nutrition (progress in clinical and biological research, vol. 304) , 1990 .

[29]  J. Uribarri,et al.  Advanced glycoxidation end products in commonly consumed foods. , 2004, Journal of the American Dietetic Association.

[30]  Cindy I Buchanan,et al.  Effects of exercise on the biomechanical, biochemical and structural properties of tendons. , 2002, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[31]  M. Shimokomaki,et al.  The chemistry of the collagen cross-links. Age-related changes in the reducible components of intact bovine collagen fibres. , 1973, The Biochemical journal.

[32]  C. A. Miles,et al.  Differences between the thermal stabilities of the three triple-helical domains of type IX collagen. , 1998, Journal of molecular biology.

[33]  Yong Ming Li,et al.  Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Bailey,et al.  Evidence for glucose-mediated covalent cross-linking of collagen after glycosylation in vitro. , 1985, The Biochemical journal.

[35]  H. Langberg,et al.  Type I collagen synthesis and degradation in peritendinous tissue after exercise determined by microdialysis in humans , 1999, The Journal of physiology.

[36]  J. Baynes Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.

[37]  M. Grynpas,et al.  Cross-link profile of bone collagen correlates with structural organization of trabeculae. , 2002, Bone.

[38]  A J Bailey,et al.  The location of three collagen types in skeletal muscle , 1977, FEBS letters.

[39]  S P Wolff,et al.  Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. , 1987, The Biochemical journal.

[40]  D. L. Price,et al.  Chelating Activity of Advanced Glycation End-product Inhibitors* , 2001, The Journal of Biological Chemistry.

[41]  H. Langberg,et al.  Time Pattern of Exercise-Induced Changes in Type I Collagen Turnover after Prolonged Endurance Exercise in Humans. , 2000, Calcified tissue international.

[42]  D. Eyre,et al.  Recent developments in cartilage research: matrix biology of the collagen II/IX/XI heterofibril network. , 2001, Biochemical Society transactions.

[43]  A. Schmidt,et al.  RAGE: A Novel Target for Drug Intervention in Diabetic Vascular Disease , 2004, Pharmaceutical Research.

[44]  K Nakamura,et al.  Acid-stable fluorescent advanced glycation end products: vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose. , 1997, Biochemical and biophysical research communications.

[45]  M. Humphries,et al.  Integrin–collagen binding , 1996 .

[46]  A. Cerami,et al.  Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. , 1986, Science.

[47]  R. G. Paul,et al.  Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes. , 1996, The international journal of biochemistry & cell biology.

[48]  A. Bailey,et al.  The role of glycation cross-links in diabetic vascular stiffening , 1996, Diabetologia.

[49]  S. Robins,et al.  Structural Characterization of Pyrrolic Cross-links in Collagen Using a Biotinylated Ehrlich's Reagent* , 2001, The Journal of Biological Chemistry.

[50]  V. Monnier,et al.  Collagen Aging In Vitro by Nonenzymatic Glycosylation and Browning , 1984, Diabetes.

[51]  H. Founds,et al.  Therapeutic potential of breakers of advanced glycation end product-protein crosslinks. , 2003, Archives of biochemistry and biophysics.

[52]  K. Biemel,et al.  Formation Pathways for Lysine-Arginine Cross-links Derived from Hexoses and Pentoses by Maillard Processes , 2001, The Journal of Biological Chemistry.

[53]  V. Monnier,et al.  Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. , 1981, Science.

[54]  A J Bailey,et al.  Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance. , 1998, Bone.

[55]  P. Bornstein,et al.  The nature and location of intramolecular cross-links in collagen. , 1966, Proceedings of the National Academy of Sciences of the United States of America.

[56]  S. Robins,et al.  Identification, expression and tissue distribution of the three rat lysyl hydroxylase isoforms , 2004, Biochemical and biophysical research communications.

[57]  M. Huijberts,et al.  Breakers of advanced glycation end products restore large artery properties in experimental diabetes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[58]  R. Nordquist,et al.  The role of nonenzymatic glycosylation, transition metals, and free radicals in the formation of collagen aggregates. , 1991, Archives of biochemistry and biophysics.

[59]  A. Bailey,et al.  Age-related changes in collagen: the identification of reducible lysine-carbohydrate condensation products. , 1972, Biochemical and biophysical research communications.

[60]  T. Andreassen,et al.  Thermal stability, mechanical properties and reducible cross-links of rat tail tendon in experimental diabetes. , 1981, Biochimica et biophysica acta.

[61]  M. Matsumoto,et al.  Rage: A Novel Cellular Receptor for Advanced Glycation End Products , 1996, Diabetes.

[62]  D. Slatter,et al.  The importance of lipid-derived malondialdehyde in diabetes mellitus , 2000, Diabetologia.

[63]  Clinton T. Rubin,et al.  Regulation of bone mass by mechanical strain magnitude , 1985, Calcified Tissue International.

[64]  H. Langberg,et al.  Time Pattern of Exercise-Induced Changes in Type I Collagen Turnover after Prolonged Endurance Exercise in Humans , 2000, Calcified Tissue International.

[65]  J. Baynes,et al.  Glycoxidation and lipoxidation in atherogenesis. , 2000, Free radical biology & medicine.

[66]  L. Kurth,et al.  Identification of the loci of the collagen-associated Ehrlich chromogen in type I collagen confirms its role as a trivalent cross-link. , 1992, The Biochemical journal.

[67]  C. Wijmenga,et al.  Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[68]  R. G. Paul,et al.  The effect of advanced glycation end-product formation upon cell-matrix interactions. , 1999, The international journal of biochemistry & cell biology.

[69]  A J Bailey,et al.  Isolation and structural identification of a labile intermolecular crosslink in collagen. , 1968, Biochemical and biophysical research communications.

[70]  P. Qvist,et al.  Characterization of Urinary Degradation Products Derived from Type I Collagen , 1997, The Journal of Biological Chemistry.

[71]  Tai Hasegawa,et al.  Crosslines A and B as candidates for the fluorophores in age- and diabetes-related cross-linked proteins, and their diacetates produced by Maillard reaction of α-N-acetyl-L-lysine with D-glucose , 1992 .

[72]  T. Metz,et al.  Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications. , 2003, Archives of biochemistry and biophysics.

[73]  A. Viidik Tensile strength properties of Achilles tendon systems in trained and untrained rabbits. , 1969, Acta orthopaedica Scandinavica.

[74]  Michael Kjaer,et al.  Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. , 2004, Physiological reviews.

[75]  K. Kivirikko,et al.  Cloning and characterization of a fifth human lysyl oxidase isoenzyme: the third member of the lysyl oxidase-related subfamily with four scavenger receptor cysteine-rich domains. , 2001, Matrix biology : journal of the International Society for Matrix Biology.